Divergent Parkinson’s Disease Burden Trajectories in China and the United States: Rising Incidence in China and Rising Mortality in the United States, 1990–2033

Background: Parkinson’s disease (PD) is a growing public health challenge in ageing societies. China and the United States, as the world’s largest developing and developed economies, represent distinct stages of demographic and epidemiological transition and differ substantially in environmental exposures and healthcare systems. We compared temporal changes in PD burden in these two countries from 1990 to 2023, examined smoking-related population attributable fractions in GBD 2023, and projected disease burden through 2033. Methods: Data on PD incidence, prevalence, deaths, disability-adjusted life years (DALYs), and age-standardized rates (ASRs) were extracted from the GBD 2023 database. Temporal trends were assessed using percentage change and estimated annual percentage change (EAPC). Age-specific patterns were examined using stratified visual analyses. We also fitted autoregressive integrated moving average (ARIMA) models with Box-Cox transformation to project age-standardized incidence, prevalence, mortality, and DALY rates from 2024 to 2033. Results: From 1990 to 2023, the absolute number of people living with PD increased markedly in both countries, rising from 781,300 to 3,445,700 in China and from 565,900 to 998,300 in the United States. After age standardization, a divergent pattern emerged. In China, incidence increased whereas mortality declined (EAPC for mortality = -0.90). In the United States, incidence remained broadly stable whereas mortality increased (EAPC = 1.67). Age-specific analyses showed that PD burden became increasingly concentrated in older adults in both countries, with the greatest burden observed in those aged 70 years and above. Smoking was the only risk factor with quantifiable PD-specific attribution data for both countries. Its PAF estimates for deaths and DALYs were negative in both settings, most prominently in Chinese males, whose negative DALY PAF was more than 10 times that in Chinese females. Forecasts to 2033 suggested modest declines in age-standardized mortality and DALYs in China, but increasing age-standardized prevalence, mortality, and DALY burden in the United States. Conclusion: China and the United States showed markedly divergent age-standardized PD burden trajectories despite increasing absolute burden in both countries. Smoking showed negative attribution in both populations, and forecasts to 2033 suggest relatively stable trends in China but further increases in prevalence and severity-related burden in the United States. These negative smoking PAFs are consistent with the widely reported inverse epidemiological association between smoking and PD, but do not imply a causal protective effect.

Authors

Publication Details

Journal
Neuroepidemiology
Published
2026-11-21
DOI
https://doi.org/10.1159/ned/adwag086
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Divergent Parkinson’s Disease Burden Trajectories in China and the United States: Rising Incidence in China and Rising Mortality in the United States, 1990–2033

莫雪妮, Peizhen Wu, Fei He, Renda He et al.
Neuroepidemiology
Parkinson's Disease Mechanisms and Treatments
article

Divergent Parkinson’s Disease Burden Trajectories in China and the United States: Rising Incidence in China and Rising Mortality in the United States, 1990–2033

莫雪妮, Peizhen Wu, Fei He, Renda He, Peiying Lu, Wei Ma, Yibao Yang, Tingting Xie
article en

Abstract

Background: Parkinson’s disease (PD) is a growing public health challenge in ageing societies. China and the United States, as the world’s largest developing and developed economies, represent distinct stages of demographic and epidemiological transition and differ substantially in environmental exposures and healthcare systems. We compared temporal changes in PD burden in these two countries from 1990 to 2023, examined smoking-related population attributable fractions in GBD 2023, and projected disease burden through 2033. Methods: Data on PD incidence, prevalence, deaths, disability-adjusted life years (DALYs), and age-standardized rates (ASRs) were extracted from the GBD 2023 database. Temporal trends were assessed using percentage change and estimated annual percentage change (EAPC). Age-specific patterns were examined using stratified visual analyses. We also fitted autoregressive integrated moving average (ARIMA) models with Box-Cox transformation to project age-standardized incidence, prevalence, mortality, and DALY rates from 2024 to 2033. Results: From 1990 to 2023, the absolute number of people living with PD increased markedly in both countries, rising from 781,300 to 3,445,700 in China and from 565,900 to 998,300 in the United States. After age standardization, a divergent pattern emerged. In China, incidence increased whereas mortality declined (EAPC for mortality = -0.90). In the United States, incidence remained broadly stable whereas mortality increased (EAPC = 1.67). Age-specific analyses showed that PD burden became increasingly concentrated in older adults in both countries, with the greatest burden observed in those aged 70 years and above. Smoking was the only risk factor with quantifiable PD-specific attribution data for both countries. Its PAF estimates for deaths and DALYs were negative in both settings, most prominently in Chinese males, whose negative DALY PAF was more than 10 times that in Chinese females. Forecasts to 2033 suggested modest declines in age-standardized mortality and DALYs in China, but increasing age-standardized prevalence, mortality, and DALY burden in the United States. Conclusion: China and the United States showed markedly divergent age-standardized PD burden trajectories despite increasing absolute burden in both countries. Smoking showed negative attribution in both populations, and forecasts to 2033 suggest relatively stable trends in China but further increases in prevalence and severity-related burden in the United States. These negative smoking PAFs are consistent with the widely reported inverse epidemiological association between smoking and PD, but do not imply a causal protective effect.

Neuroepidemiology
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon